Format

Send to

Choose Destination
Intern Med J. 2017 Aug;47(8):848-855. doi: 10.1111/imj.13348.

Spleen Australia guidelines for the prevention of sepsis in patients with asplenia and hyposplenism in Australia and New Zealand.

Author information

1
Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
2
Dentistry and Health Sciences, Faculty of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
3
Spleen Australia, Department of Infectious Diseases, Alfred Health, Melbourne, Victoria, Australia.
4
Infection Prevention and Healthcare Epidemiology Unit, Alfred Health, Melbourne, Victoria, Australia.
5
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
6
Pharmacy Department, Alfred Health, Melbourne, Victoria, Australia.
7
University of Auckland and Starship Children's Hospital, Auckland, New Zealand.
8
Microbiology Unit, Department of Pathology, Alfred Health, Melbourne, Victoria, Australia.

Abstract

People with asplenia/hyposplenism are at increased risk of fulminant sepsis, which carries a high mortality rate. A range of preventive measures is recommended although there is ongoing evidence that knowledge of and adherence to these strategies is poor. There have been significant changes in recommended vaccinations since the previously published recommendations in 2008. We provide current recommendations to help Australian and New Zealand clinicians in the prevention of sepsis in patients with asplenia and hyposplenia. The guideline includes Australian epidemiological data, preferred diagnostic techniques and recommendations for optimal antimicrobial prophylaxis and vaccination protocols.

KEYWORDS:

asplenia; guideline; hyposplenism; prevention; sepsis

PMID:
27925427
DOI:
10.1111/imj.13348
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center